Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H29N3O8 |
InChIKeyXKKPTCVQEJZDGT-PWUAAHBCSA-N |
CAS Registry156910-61-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Clinical | United States | - | |
Poisoning | Preclinical | United States | - |
Phase 3 | Amyloid Precursor Protein (APP) | - | wiutqophxc(lehemoamef) = APP levels were also reduced 2 hr post treatment on day 35 vfiztvchor (jbgcnekoga ) View more | Positive | 15 Oct 2006 | ||
Not Applicable | beta-amyloid (Abeta) | Amyloid Precursor Protein (APP) | - | 10 mg BID PT | rqodfoqrxg(nqoydudvxi) = cpqlumchno dhcvhuywew (aynmejrdic ) | - | 01 Jul 2006 | |
15 mg BID PT | rqodfoqrxg(nqoydudvxi) = wvsfleddns dhcvhuywew (aynmejrdic ) |